Novakand Pharma AB (publ) (LARK) — Financial Flexibility Index
Novakand Pharma AB (publ) (LARK) has a Financial Flexibility Index of -1.32x as of December 2025. Free cash flow of Skr-1.64 Million (operating CF Skr-1.64 Million minus capex Skr0.00) represents -1% of total liabilities (Skr1.24 Million). Check how resilient are Novakand Pharma AB (publ)'s assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Novakand Pharma AB (publ) Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Novakand Pharma AB (publ) across 14 annual periods. See working capital to net assets of Novakand Pharma AB (publ) to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Novakand Pharma AB (publ) (2012–2025)
Year-by-year free cash flow to debt coverage for Novakand Pharma AB (publ). For the full company profile including market capitalisation, see Novakand Pharma AB (publ) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -10.31x | Skr-12.78 Million | Skr-12.78 Million | Skr1.24 Million | ▼ -48.1% |
| 2024 | -6.96x | Skr-29.95 Million | Skr-29.95 Million | Skr4.30 Million | ▲ +4.9% |
| 2023 | -7.33x | Skr-30.45 Million | Skr-30.56 Million | Skr4.16 Million | ▼ -168.1% |
| 2022 | -2.73x | Skr-16.67 Million | Skr-16.67 Million | Skr6.10 Million | ▼ -197.5% |
| 2021 | 2.80x | Skr22.26 Million | Skr22.11 Million | Skr7.94 Million | ▲ +158.5% |
| 2020 | -4.79x | Skr-38.24 Million | Skr-38.35 Million | Skr7.98 Million | ▼ -421.5% |
| 2019 | -0.92x | Skr-21.60 Million | Skr-21.60 Million | Skr23.51 Million | ▼ -2147.8% |
| 2018 | 0.04x | Skr657.80K | Skr227.60K | Skr14.66 Million | ▲ +100.8% |
| 2017 | -5.86x | Skr-9.53 Million | Skr-9.53 Million | Skr1.63 Million | ▲ +45.7% |
| 2016 | -10.78x | Skr-8.73 Million | Skr-8.81 Million | Skr809.66K | ▼ -24.6% |
| 2015 | -8.65x | Skr-5.99 Million | Skr-6.29 Million | Skr691.73K | ▼ -711.4% |
| 2014 | -1.07x | Skr-620.67K | Skr-620.67K | Skr582.04K | ▲ +83.9% |
| 2013 | -6.64x | Skr-272.15K | Skr-272.15K | Skr40.98K | ▼ -3426.4% |
| 2012 | 0.20x | Skr59.21K | Skr59.21K | Skr296.58K | — |